Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MiNK Therapeutics, Inc. (INKT) had Return on Tangible Equity of 87.82% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.49M |
|
-- |
|
-- |
|
$12.64M |
|
$-12.64M |
|
$0.15M |
|
$-12.49M |
|
$-12.49M |
|
$-12.49M |
|
$-12.49M |
|
$-12.49M |
|
$-12.49M |
|
$-12.64M |
|
$-12.46M |
|
4.27M |
|
4.27M |
|
$-2.93 |
|
$-2.93 |
|
| Balance Sheet Financials | |
$13.85M |
|
$0.39M |
|
$0.39M |
|
$14.24M |
|
$13.03M |
|
-- |
|
$15.44M |
|
$28.47M |
|
$-14.23M |
|
$-14.23M |
|
$-14.23M |
|
4.71M |
|
| Cash Flow Statement Financials | |
$-5.93M |
|
-- |
|
$14.72M |
|
$4.58M |
|
$13.36M |
|
$8.78M |
|
$2.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
-- |
|
-0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.82% |
|
|
Return on Tangible Equity |
87.82% |
-87.75% |
|
87.82% |
|
$-3.02 |
|
$-1.39 |
|
$-1.39 |
|